Physician profile
Stephen Behrman
NPI 1942266713
$606.48
in general payments reported to CMS, 2019-2025
12 companies · $194 in 2025
The $194 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.72 · 2022: $207 · 2023: $18.83 · 2024: $117 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $167.30 | 2022 | |
| Dilon Technologies, INC. | $110.59 | 2025 | Hemoblast Bellows |
| W. L. Gore & Associates, INC. | $78.43 | 2024 | Gore Bio-A Tissue Reinforcement |
| Nestle Healthcare Nutrition INC. | $58.89 | 2022-2023 | |
| Aimmune Therapeutics, INC. | $58.79 | 2024-2025 | Zenpep |
| Solventum Corporation | $33.18 | 2025 | V.A.C. Veraflo Cleanse Choice, Abthera, Prevena |
| Philips North America LLC | $21.26 | 2019 | |
| Smith+Nephew, INC. | $18.29 | 2019 | |
| Boston Scientific Corporation | $16.88 | 2025 | General - Pain Management |
| Livanova USA, INC. | $16.61 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.56 | 2019 | |
| Kerecis Limited | $12.70 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Behrman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.